Viewing negative mentions of gene expression of Pdcd1 (M. musculus) in T cells

Full-text article links are indicated by after the article reference.

Document Target Regulator Anatomy Sentence
Yadav et al. (2007)PD-1T cellsImmunophenotypic analysis of T and APCs revealed a significantly lower frequency of T cells expressing the negative costimulatory receptor PD-1 in B7-1KO mice whereas the proportion of B7-H1 positive APCs was found to be significantly higher.
Wang et al. (2007)PD-1T cellsAlloreactive PD-1(-/-) CD4 and CD8 T cells had enhanced proliferation and cytokine production compared to wild-type controls, and anergy could not be induced in PD-1-deficient CD4 T cells.
Ahmadzadeh et al. (2009)PD-1T cellsPD-1(+) TIL expressed CTLA-4 and Ki-67, markers that were not expressed by PD-1(-) TIL and T cells in the normal tissues and PBL.
Nakamoto et al. (2009)PD-1-highT cellsOf note, CTLA-4 was preferentially expressed in PD-1-high, but not PD-1-intermediate or PD-1-negative CD8 (Figure 1D) and CD4 T cells (data not shown) with a strong association between PD-1 MFI and CTLA-4 expression in percentage (R?
Wan et al. (2006)PD-1T cellsIn this study, initial analysis of costimulatory molecules led to the unexpected observation that, in addition to CD80, several negative regulators (e.g., CTLA-4, programmed death-1 (PD-1), and PD ligand-1) were overexpressed in synovial T cells and macrophages derived from RA patients as opposed to controls.
Ghebeh et al. (2008)PD-1T-lymphocytesThe cut off point for positive and negative for FOXP3, B7-H1 and PD-1 was 5% (5% of total CD3+ T-lymphocytes).
Dorfman et al. (2006)PD-1T cellIn a study of a wide range of lymphoproliferative disorders, neoplastic T cells in 23 cases of angioimmunoblastic lymphoma were immunoreactive for PD-1, but other subtypes of T cell and B cell non-Hodgkin lymphoma, as well as classic Hodgkin lymphoma, did not express PD-1.
Schurgers et al. (2010)PD-L1T cellA role for inducible nitric oxide (iNOS), programmed death ligand-1 (PD-L1) and prostaglandin E2 (PGE2), but not indoleamine 2,3-dioxigenase (IDO), in the T cell inhibition was demonstrated.
Cohen et al. (2009)PD1T cellsThe remaining lines either did not express PD1 (3/10) or had aberrant expression patterns (5/10) on whole PBL, T cells and B cells (Figure 4A).